Protein,Epitope Type,Sequence,Length,Start Position,Allele,%Rank / Percentile Rank,Binding Strength,Notes / Priority,
Omp19,MHC-I (CTL),KAYDAELAK,9,58,BoLA-2:01201,0.01,Very Strong,"Overlaps B-cell cluster, top binder",
Omp19,MHC-I (CTL),KAADALAVK,9,49,BoLA-2:01201,0.04,Strong,"Very low rank, high priority",
Omp19,MHC-I (CTL),ALVAGCSAH,9,11,BoLA-1:00901,0.11,Strong,"Good affinity, likely surface-exposed",
Omp19,MHC-I (CTL),MKKTLVLSL,9,1,BoLA-T2c,2.1,weak,Very low rank,
Omp19,MHC-I (CTL),LVLSLVALV,9,5,BoLA-T2c,2.3,weak,Very low rank,
Omp19,MHC-II (HTL),ALAVKKAYDAELAKK ,15,-,BoLA-DRB3_0201,1.12,good,"Reasonable affinity, central region",
Omp19,MHC-II (HTL), DALAVKKAYDAELAK ,15,-,BoLA-DRB3_0201,2.05,strong,"Very good rank, high priority",
Omp19,MHC-II (HTL), LAVKKAYDAELAKKA  ,15,-,BoLA-DRB3_0202,4.23,strong,"Strong binder, overlaps with CTL region",
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,Summary for Omp16 table,,,,,,,
,,MHC-I candidates shown: 6,,,,,,,
,,MHC-II candidates shown: 4,,,,,,,
,,"Recommended to keep: 5–7 (e.g., 3 CTL + 2–3 HTL)",,,,,,,
